Furthermore, we found increased sensitivity to dual inhibition with sapitinib or the AKT/PI3K inhibitor in the HCC-70 and MDA-MB-468 cell lines more effectively compared the MDA-MB-231 cell line (Figure S3A). Here, AKT1 is linked to hepatocellular carcinoma.